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Abstract - General anesthesia is well known to
offer physicians access to a broad variety of
invasive procedures otherwise deemed too
risky. Anesthesia machines provides the means
for anesthetizing patients safely in the hospital
operating room. However, these devices are
increasingly unable to meet the demands and
needs outside of the hospital. Developing
countries struggle to purchase and maintain
these costly devices, leading to a 40-fold
increase in anesthesia-related deaths compared
to developed countries. Small-office practices
in the United States experience significantly
poorer anesthesia outcomes and increased legal
claims
versus
their
larger
hospital
counterparts, resulting in 60% more
anesthesia-related deaths.
Environmental
impacts and global health concerns from the
emitted anesthetic gases have brought into
serious question the prevailing notion that
unchecked emissions were sustainable. These
factors can all be attributed to anesthesia
machine design and technology having the
primary intended use in the traditional
operating room. The long-term goal of this
work is to develop technologies in anesthesia
that expand its safe use, decrease underlying
costs, and reduce the total emissions. The
immediate objective of this work is to create a
feedback-controlled anesthetic gas vaporizerscavenger system and evaluate its performance.
The central hypothesis is that the combined use
of mesoporous materials and feedback control
provide the opportunity for repeatable capture
and release of expired anesthetic gases during
anesthesia delivery. Our rationale is that such
a device will help reduce the amount of
anesthetic needed while simultaneously offering
improved control over the delivery of anesthetic
gases.

I. INTRODUCTION
Anesthesia machines and systems are at the center
of surgical care and provide support for
anesthesiologists to administer anesthesia. These
devices provide a multitude of functions, including
confirming intubation, monitoring cardiopulmonary function, delivering both intravenous
and inhalational anesthetic gases, and determining
the depth of unconsciousness for a given patient.
Historically anesthesiology represented one of the
risker aspects of medicine, however several
technological advances have led to a drastic
improvement in anesthesia safety in the hospital,
transforming it from one of the most dangerous
aspects of surgery to one of the safest. 1–5 While
these improvements are welcome, many diverse
problems still exist in anesthesia that need to be
addressed in a new era of technologies.
II. ISSUES IN ANESTHESIA
Global Access to Anesthesia
There are 5 billion people globally that still have
inadequate access to anesthetic care, primarily in
South Asia and Sub-Saharan Africa.6 Hospitals in
austere conditions that have been able to provide
anesthetic care have been unable to match the
reduction in anesthesia-related morbidity and
mortality seen in the developed world.7,8 This
discrepancy stems from a combined lack of
clinical staff, equipment, space, and systems of
surgical care delivery.9,10 Significant efforts have
been made to increase access to clinical staff,
primarily through increases in local education
programs as well as humanitarian efforts through
programs like Médecins Sans Frontières (MSF,
also known as Doctors Without Borders).11–14
Deficits in technical resources and equipment
remain an unsolved problem none the less. Lack
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of healthcare resources and infrastructure has led
many developing countries to import equipment
despite it being ill-suited for the environment.
Much of this healthcare equipment is being funded
by both international donors and foreign
governments, with donations comprising nearly
80% of the incoming anesthesia equipment for
some developing countries.15 Despite these
donations, the expertise and parts required to
maintain them leads to as little as 10% of these
donated machines ever becoming operational.9,16
Rudimentary anesthesia machines have been
developed in an effort to overcome this issue by
incorporating uninterruptible power supplies,
oxygen concentrators, and simple draw over
vaporizers.17,18 While certainly beneficial, these
anesthesia machines still fail to provide any access
to patient monitoring, the primary method by
which clinicians prevent anesthesia-related
morbidity and mortality in the developed world.19
Additionally these devices do nothing to address
the need of anesthetic scavenging systems in
resource-limited settings.11
Ultimately, this
resource gap contributes to a scarcity of operating
facilities in low resource areas, with the estimated
number of operating rooms being more than 25
times less than high-income regions, culminating
in a 40 fold increase in anesthesia-related death.8,9
Increases in U.S. Anesthesia Complications
The economics and demands of healthcare in the
United States are pushing anesthesia from inhospital to outpatient and small-office settings,
raising concerns over quality of care and patient
safety.20 Initial lack in mandatory accreditation of
small office anesthesia practices may have
contributed to a marked increase in adverse events
in anesthesia. An ASA Closed Claims analysis
showed that for small office claims, more than
40% of monitored anesthesia care (MAC) claims
involved permanent brain damage and 21% of
MAC claims had unaddressed respiratory
depression, half of which were deemed
preventable by better patient monitoring.21 While
new mandatory accreditation and stricter state
regulation have improved these outcomes in smalloffice practice, there still remains a discrepancy in
the standard of care compared to hospitals.22,23
The capital cost, space requirements, and necessity

for scavenging systems in anesthesia machines
cause many clinicians to turn to total intravenous
anesthetics (TIVA) without the safety net of
ventilation equipment or monitoring, a primary
contributing factor of these negative outcomes.24
Due to their higher fat solubility, intravenous
anesthetics often result in drug accumulation and
then subsequent delays in recovery once infusion
has stopped.25 More importantly, the inability
measure drug concentration, and therefore
anesthetic depth, is the most pronounced reason
for avoiding intravenous anesthetics. As a result,
titrating a dose correctly requires an experienced
clinician to account for patient variability,
nonlinear relationships between dose and effect,
and the synergistic effects between drugs. In a
study of 90 patients receiving either propofol (an
intravenous anesthetic), isoflurane, or desflurane
(both inhalational anesthetics) for anesthesia
maintenance, the percentage of patients with
purposeful movement was 63% for those who
received propofol, and only 23% and 6.7% for
those receiving isoflurane and desflurane
respectively.26 Attempts have been made to
monitor the effects of intravenous anesthetics on
the brain using the Bispectral Index (BIS),
however there exists widespread controversy on its
consistency in determining patient awareness.38
In contrast, inhalational anesthesia is set by
alveolar concentration, which has a far more
robust and established relationship to effect.27
Inhalational anesthesia has also shown to be
preferable for induction and maintenance in
pediatric cases, as children often have a fear of
needles, and inhalational induction is painless and
entirely noninvasive.28
Finally, because
inhalational anesthesia is delivered by
concentration and not dose, the maximum
concentration in the body is capped, decreasing the
likelihood of overdose.
Environmental Impacts of Anesthesia
Alongside the need for patient monitoring, the
ability to safely scavenge expired anesthetic gases
from the anesthesia machine and away from
clinicians remains another hurdle outside of the
hospital.11,29–31 This hurdle encourages the use of
TIVA over inhalational anesthetics at both
increased financial cost and risk of undetected
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respiratory depression.24 Even with appropriate
anesthetic scavenging or respiratory monitoring, a
secondary impact of inhalational anesthetics is the
negative environmental impact.32
Anesthetic
gases have a global warming potential more than
3700 times that of carbon dioxide and contribute
to over 1% of the global ozone depletion despite
the relatively small size of anesthesia
emisisons.33,34 The introduction of semi-closed
anesthesia rebreathing circuits and low fresh gas
flow techniques have reduced anesthetic waste, but
these still require scavenging systems and
additionally
necessitate
carbon
dioxide
35,36
scrubbing.
This environmental impact could
be dismissed in the face of immediate patient
health. However, it is estimated the damages
generated by health-care industry pollutants well
exceed the 44,000-98,000 who die annual due to
preventable medical errors.37,38 In anesthesia,

volatile agent release marks the primary
environmental burden (Figure 3.1-1).39,40
A system that “reflects” anesthetics back to the
patient would remove the need for a scavenging
and carbon dioxide removal while also
significantly reducing the environmental impact of
anesthesia by reintroducing open non-rebreathing
circuits. Removing carbon dioxide scrubbing has
additional benefits beyond costs and complex
logistics. The absorbents used can cause inhaled
anesthetics to degrade into carbon monoxide,
particularly during low fresh gas flow and when
the absorbent is desiccated, with concentrations
being lethal in porcine experiments and posing
significant risks to pediatric patients.41,42 Open
breathing circuits additionally reduce the
technological barriers to using volatile anesthetics
in tandem with sophisticated ICU ventilators,
potentially allowing for the use of volatile agents

Figure 3.1-1 Total life cycle environmental impacts of an average hysterectomy by surgery type (normalized to highest hysterectomy type
in impact category). Negative values reflect positive environmental impacts due to recycling; Error bars represent 90% confidence interval
from Monte Carlo Analysis.11
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in long-term sedation in the ICU.
Porous
materials, such as activated charcoal, have been
shown effective in capturing anesthetics.43 Once
saturated, however, the adsorption and release of
anesthetic gas could occur rapidly, allowing for
capture during exhalation and reflection at
inhalation, while simultaneously allowing carbon
dioxide, oxygen, and nitrogen to pass freely. This
research focuses of a variety of technological
advances in anesthesia delivery to address these
issues.
III.

INNOVATIONS IN ANESTHESIA

Improving Monitoring in Anesthesia
Current methods of measuring anesthetic gas
concentrations rely on the unique infrared
absorption profile of each anesthetic gas.
Determining the concentration therefore requires a
variety of infrared filters to identify specifics
absorptions peaks, followed by measuring the
concentration via the Lambert-Beer Law. While
effective, infrared spectroscopy is cost-intensive
due to the optics required to continuously measure
the adsorption of various infrared wavelengths.
However, using differences in gas density using
orifice-plate flow sensors poses an alternative
method for measuring gas concentrations in binary
mixtures. Orifice-plate flow sensors traditionally
determine fluid velocity utilizing Bernoulli’s Law
(Figure 3.2-1). Given a known fluid velocity, they
can instead be used to determine fluid density. By
combining an orifice-plate sensor with an
additional fluid velocity sensor independent to
changes in density, the total fluid velocity and
composition can be determined. This concept has
been proven feasible for measuring various
mixtures of helium, carbon dioxide, argon, and
room air.44–46 However, no one has yet developed
an anesthetic gas sensor using this technique. The
difference in density between anesthetic gas and
room air nearly matches the difference between
room air and helium (5 times and 6.8 times greater
respectively). The accuracy of these devices is
also much higher than infrared spectroscopy, with
the percent error for such a device being between
±7.5% by volume compared to ±16.7% by volume
for infrared spectroscopy.44,47

Furthermore, most flowmeters are sensitive to the
presence of anesthetic gases.
As a result,
combining sensors with varying sensitivities to
anesthetic gas concentrations can yield both a
more accurate flow measurement as well as an
anesthetic agent concentration. Statistical tools
like Principal Component Analysis excel and
determining what factors contribute to the
measured signal. As a result, current testing is
expanding beyond simply orifice-plate sensors and
including hot-wire anemometers, spinning vane
anemometers, ultrasound-doppler, ultrasound
time-of-flight, and other hybrid sensors.

Figure 3.2-1 Cutaway of an orifice plate flow meter. As gas flows
through the orifice, it generates a pressure difference described by
Bernoulli’s Law. Alternatively, the phenomenon can instead by
used to determine fluid density.

Characterizing Mass Transfer of Anesthetics in
Porous Materials
Our key innovation is developing a new method
for reusing expired anesthetic gases through
continuous, reversible sorption via mesoporous
materials. Mesoporous materials have long been
used for capturing volatile organic compounds, in
some cases reversibly.48 Utilizing mesoporous
materials to reflect anesthetic gases is not an
entirely novel idea, however it is poorly explored
and understood.49 The broad spectrum of pore
sizes in activated charcoal has made it the material
of choice for feasibility testing. However, other
materials have remained untested in their ability to
specifically capture and release anesthetic gases.
We have previously measured the rate of release of
release of isoflurane from activated charcoal.50 In
a similar way, we are investigating the effects of
pore size, material affinity, flow rate, and
gas/adsorbed phase concentration on the sorption
isotherm with isoflurane, sevoflurane, and
desflurane.
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Feedback Control of Capture and Release of
Anesthetic Gases
Reflecting anesthetic gas back to the patient
through the means of a porous medium would
represent a unique method for volatile anesthetic
agent recovery and delivery. If this method of
anesthetic delivery is successful, it would allow for
anesthesia breathing circuits that remove
scavenging systems, carbon dioxide scrubbers, and
significantly reduce the amount of anesthetic used
and wasted during anesthetic maintenance.
Previously explored was incorporating such a
device into the rebreathing circuit of an anesthesia
machine. Such a device was able to show that over
the course of a 2 hour mock surgery, activated
charcoal is capable of reducing the anesthetic gas
needed by over 90% and anesthetic concentrations
were maintained to a given set point.50,51 Future
iterations depend largely on the material
capabilities found in ongoing research, with this
system being feasibly incorporated at various
stages in the anesthesia breathing circuit, each with
distinct advantages and disadvantages such as
range of flow rates and synchrony with patient
ventilation. In addition, incorporating feedback
control into this device will enable a higher level
of efficiency in anesthetic gas delivery and
recovery. The basic principle of feedback control
consists of measuring the difference between the
feedback signal (anesthetic gas concentration) and
the desired set point. A controller utilizes
algorithms to then produce a related output that
reduces this difference. The related output is
converted to changes in an actuator (variable flow
bypass, temperature, pressure, etc.) to illicit a
physical change in concentration that better
matches the set point. Feedback control systems,
when implemented corrected, allow for more
stable, accurate, and fast systems. Ultimately, a
device that results in a faster step response then has
additional applications in patient-included closedloop feedback control using pharmacokinetics and
pharmacodynamics, target-controlled anesthesia,
time course delivery, etc.52–54 These closed-loop
autonomous systems have been shown to result in
better control over the delivery of anesthesia with
significant reduction in dose overshooting and
undershooting.55

Figure 2.1-1 A radial blower (1) passes air through a variable
valve (2) which can be actuated to scavenge anesthetic from the
circuit through a filter (3). A differential pressure flow sensor
measures changes in flow and density (4), while a test lung (5) is
ventilated by changes in pressure caused by changed in flow from
the blower and a fluid resistor (6). Isoflurane can be injected into
the system using a custom vaporizer (7) and a reservoir bag (8)
adds extra volume to ventilate the test lung.

II. METHODS
Sensor Fusion for Anesthetic Concentration
Sensing
A custom anesthesia machine was created,
consisting of a fresh oxygen inlet, anesthetic
vaporizer, charcoal scavenging outlet, and custom
rebreathing circuit. The custom rebreathing circuit
consisted of a radial turbine with fluid resistor and
differential pressure sensor anteriorly. The fluid
resistor enabled flow changes from the radial
turbine to yield pressure changes in that leg of the
circuit, allowing for the ventilation of a
mechanical lung simulator (TTL Michigan
Testlung, Michigan Instruments, Grand Rapids,
MI). Finally, posterior to the radial turbine was a
reservoir bag (Figure 2.1-1). Data was collected
from the radial turbine tachometer and differential
pressure sensor, both serving as indicators of gas
flow. Several tests were performed to characterize
the behavior of these sensors in various conditions.
This included steady state flow tests ranging from
2-60 liters per minute to calibrate both sensors
using a standard gas flow bench (VT-Plus Gas
Flow Analyzer, Fluke Corp., Everett, WA),
cyclical tests to determine and correct for
hysteresis between the tachometer and the
differential pressure sensor, and verification tests
to ensure the tachometer’s independence in
measured flow with the presence of isoflurane.
Once a baseline with no anesthetic gas had been
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determined, the radial turbine was set to ventilate
a test lung at 12 breaths per minute, with a tidal
volume of 500 milliliters. Isoflurane was then
introduced into the system at concentrations
ranging from 0-3.0%, which was measured using
a standard infrared gas bench (Datex-Ohmeda,
Helsinki, Finland).
The difference in flow
measured by the differential pressure sensor from
the turbine tachometer was attributed to changes in
the gas density, and therefore isoflurane
concentration. This difference was then passed
through a simple alpha-beta filter and used to
estimate the isoflurane concentration. This result
was then compared to the infrared gas bench. All
sensors were sampled at 20 Hz.
Sorption Isotherm of Porous Materials with
Anesthetic gases
Two generalized tests were performed to better
understand the general behavior of activated
charcoal and anesthetic gases. The first test
consisted of a 5 L/min flow of oxygen containing
5% isoflurane (Piramal Healthcare Limited,
Andhra Pradesh, India) to be passed through a
cylindrical vessel containing 42 grams of activated
charcoal (Oxpure 1220C-75, Oxbow Activated
Carbon, West Palm Beach, FL) until 0.5%
isoflurane pushed through (approximately 10
minutes). The vessel was sealed and weighed to
determine the amount of anesthetic gas adsorbed
onto the surface of the charcoal. Next, a gas flow
containing pure oxygen was pushed through the
vessel at a rate of 2 L/min and the concentration of
anesthetic gas leaving the vessel was measured.
The same process was repeated with non-porous
beads as a control. A second test consisted of a
smaller vessel containing 10 grams of partiallysaturated activated charcoal (total weight of 14
grams) placed between the Y-piece of an
anesthesia circuit and a mechanical lung simulator
(TTL Michigan Testlung, Michigan Instruments,
Grand Rapids, MI). This test lung was then driven
using a ventilator and 100% oxygen, with the
concentration of isoflurane between the vessel and
test lung being monitored. A control was
performed with non-porous beads.

Anesthetic Gas Scavenger-Vaporizing Device
Test
An initial proof-of-concept prototype was
demonstrated and fitted within the rebreathing
circuit of a current anesthesia. This system
consisted of a housing with two chambers, one
fitted with a charcoal cartridge, and the other open
to free gas flow. A gear with a semicircular
opening was actuated externally to determine
which chamber, or combination of chambers, had
fresh gas traveling through from the anesthesia
machine to the simulated lung. In addition,
differential pressure sensors were attached at both
chambers to detect inhalation and exhalation.
Anesthetic gas concentration measurements from
a standard infrared gas bench was used for basic
feedback control. A microcontroller controlled the
orientation of the gear valve to titrate the
anesthetic concentration based on breath detection,
anesthetic gas concentration, and a user input for
desired anesthetic concentration using a
rudimentary hysteresis controller.
III. RESULTS
A. Anesthetic Concentration Sensing
The mean difference in measured isoflurane
concentration
to
estimated
isoflurane
concentration was -0.025% volume, with a
standard deviation of 0.091% volume. In a total of
over 26,000 measurements, 95% of the estimated
isoflurane concentrations fell within 0.2% volume
of the measured isoflurane concentration, which is
within the accuracy limitations of the infrared gas
bench itself (Figure 3.1-1). No statistically
significant difference was found in estimating the
isoflurane concentration in pure oxygen versus
room air.
B. Sorption Isotherm of Porous Materials
Isoflurane was released at concentrations suitable
for anesthesia maintenance for a significant
amount of time, approximately 10 minutes (Figure
3.2-1). Ventilation was also tested to investigate
more dynamic conditions where the device was
ventilated with a test lung (Figure 3.2-2). Once
saturated, the activated charcoal had absorbed
approximately 60% of its total weight in isoflurane
and was capable of repeatedly reflecting 10% of its
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total weight in isoflurane or about 3.2 mL of liquid
isoflurane. This volume of isoflurane capable of
being reflected is the equivalent of anesthesia
maintenance at 1 MAC for 1 hour at a fresh gas
flow rate of 1 liter per minute.
C. Prototype Device Design
A prototype was successfully created and could
perform the basic desired functions. Specifically,
inspiratory and expiratory flows were detected and
a basic “bang-bang” feedback control was
implemented to achieve the desired concentration.
Once the charcoal had been saturated from a mock
anesthesia induction, the controller was able to
maintain average isoflurane concentrations within
0.2% by volume of the user set point (1.2% by
volume).
Figure 3.1-1 Plot of the measured anesthetic concentration versus
the estimated anesthetic concentrations (top) along with a BlandAltman analysis of the two sensors against each other (bottom).

Figure 3.2-1 The observed concentration of isoflurane leaving the
vessel containing 40 grams of saturated activated charcoal as the
flow was reversed at 2 liters per minute. The activated charcoal
(black) allowed for the gradual released of isoflurane compared to
the control (red) containing no activated charcoal.

Figure 3.2-2 The observed concentration of isoflurane during
ventilation between 10 grams of activated charcoal and the test
lung. Activated charcoal (grey) allowed for the gradual released of
isoflurane compared to the control (pink). A running average is
shown for both the activated charcoal (black) and control (red).

IV. DISCUSSION
Activated carbon has been shown to readily
absorb and release anesthetic gases. Creating a
system using this material would allow for the
implementation of an activated carbon reflector
that absorbs, holds, and releases anesthetic gases
back to the patient. Not only would this remove
the need for an anesthetic scavenging system, but
it would also significantly decrease the cost of
anesthetic maintenance by reducing the amount
of gas vaporized. Preliminary data has shown that
40-mesh activated carbon can capture anesthetic
gases and release them with reversed flow at a
concentration high enough for sedation. By
combining this material with a novel breathing
circuit design, we will remove the need for a
scavenging system and expand the environments
in which anesthesia can be used. Success in this
research will ultimately reduce the cost,
infrastructure, and expertise needed to deliver
general anesthesia. By doing this, the global
access to anesthesia and surgical will be greatly
increased, reducing the suffering in the world.
Future designs will include a dual column system
that oscillates between a vaporizing column and a
recovering column (Figure 3.2-3). The system is
designed so that it can be used with the circle
breathing system and ventilator of a typical
anesthesia machine. In this system one column
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Figure 3.2-3 Schematic of the proposed Scavenging-Vaporizing System and how it functions with a commercial ventilator. Within the system
exists two columns alternating in function between vaporizer and scavenger. These roles are determined through the actuation of valves. Not
shown is an anesthetic gas reservoir used if neither column can deliver the set concentration of anesthetic, as well as a fresh gas bypass for
when no anesthetic is needed.

vaporizes anesthetic gas into the fresh gas flow,
while the other column simultaneously scavenges
exhaled anesthetic gas from the waste stream.
When either the vaporizing column begins to
deplete, or the scavenging column begins to fully
saturate, a series of valves reverse the roles of each
column and continue the process indefinitely. A
fresh gas bypass will also be included to both
titrate the vaporizing column accordingly and
allow for pure oxygen delivery when anesthetic
gas is no longer needed. A feedback controller
based off an anesthetic gas concentration sensor at
the inspiratory limb of the proposed system will
further control the fresh gas bypass for increased
accuracy and stability. By placing the feedback
sensor in the inspiratory limb, the patient remains
out of the feedback loop, thereby avoiding
regulatory hurdles associated with patientincluded feedback control systems like targetcontrolled infusion. If both columns are depleted
and can no longer maintain set anesthetic gas
concentrations, a reservoir of anesthetic gas
separate from the columns will be used to deliver
anesthetic gas and re-saturate the entire system.
This system will not require any additional work

from the clinician as it will be designed to maintain
an anesthetic gas concentration set by the clinician,
similar to conventional anesthetic gas vaporizers.
However, unlike conventional anesthetic gas
vaporizers, this system limits clinicians to a single
volatile anesthetic for each case and requires that
each column be replaced between cases. While
there will still be some remaining volatile
anesthetic gas in each discarded column, the
overall anesthetic gas used will remain
substantially lower.
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